LungQ™ Clinical Suite
Aiding clinical specialists in best possible patient care
Intelligent AI-powered analysis of thoracic CT scans, developed for specialized clinical trials and interventional pulmonology, is now available as a reliable and user-friendly application for clinical use. LungQ™ Clinical Suite enables efficient workflows in diagnosis and treatment planning for the most common diseases such as Asthma, COPD and Bronchiectasis. It also provides statistically powerful insights for tackling rare and complex conditions, such as Cystic Fibrosis and Idiopathic Pulmonary Fibrosis.
Efficient integration into clinical workflows
Precise diagnosis and treatment planning
Accurate and reliable quantifications
Clinically validated and regulatory compliant
AI Workflow
The conventional clinical care process is usually quite time-consuming for the radiologist and can be error-prone due to the extent of effort required. AI-assisted workflow has been proven to streamline the process of getting personalized care. With the help of LungQ Clinical Suite physiologists can get precise quantifications fast and provide treatment plans faster.
Use cases
Emphysema and fissure completeness in COPD
LungQ’s COPD module provides quantitative analysis of the extent and distribution of lung emphysema and fissure completeness. These assessments support clinical decision making and accurate referral of late-stage COPD patients. For specialized interventional pulmonologists, emphysema and fissure assessment supports treatment planning and allows targeted intervention.
LungQ’s COPD module builds on Thirona’s expertise in interventional pulmonology, providing measurements that are being used at more than 300 hospitals for treatment planning support.
Certified for Europe. FDA 510(k) cleared.
COVID-19 severity assessment for diagnostic support
LungQ’s COVID-19 module provides a quantitative assessment of COVID-19 infection severity in the lung. Percentages of affected lung area relate to the severity and stage of disease, supporting fast and accurate diagnosis and treatment decisions. Quantitative, anatomically precise assessments are valuable for objective monitoring of disease progression and recovery.
LungQ’s COVID-19 module is an integrated version of CAD4COVID-CT, which has contributed to diagnosis of COVID-19 on more than 10,000 CT scans of patients in 30 countries worldwide.
Certified for Europe. FDA permitted the software to be used in the USA. Not available for sale in the USA.
Interested in a clinical integration?
Having built solid domain expertise and a strong AI-powered technology backbone, we are now
making the tools available to all clinical users through partnerships and integrations.
Let's explore the partnership opportunities!
Interested in a clinical integration?
Having built solid domain expertise and a strong AI-powered technology backbone, we are now making the tools available to all clinical users through partnerships and integrations.
Let's explore the partnership opportunities!
